AngioDynamics Inc (ANGO)
6.85
+0.17
(+2.54%)
USD |
NASDAQ |
Nov 04, 13:06
AngioDynamics Enterprise Value: 221.24M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 221.24M |
| October 31, 2024 | 221.64M |
| October 30, 2024 | 231.39M |
| October 29, 2024 | 231.80M |
| October 28, 2024 | 224.08M |
| October 25, 2024 | 223.27M |
| October 24, 2024 | 237.90M |
| October 23, 2024 | 239.93M |
| October 22, 2024 | 245.21M |
| October 21, 2024 | 215.55M |
| October 18, 2024 | 209.45M |
| October 17, 2024 | 207.42M |
| October 16, 2024 | 202.54M |
| October 15, 2024 | 207.01M |
| October 14, 2024 | 211.89M |
| October 11, 2024 | 209.86M |
| October 10, 2024 | 199.29M |
| October 09, 2024 | 196.85M |
| October 08, 2024 | 188.73M |
| October 07, 2024 | 197.67M |
| October 04, 2024 | 197.67M |
| October 03, 2024 | 208.64M |
| October 02, 2024 | 260.65M |
| October 01, 2024 | 259.84M |
| September 30, 2024 | 265.93M |
| Date | Value |
|---|---|
| September 27, 2024 | 261.06M |
| September 26, 2024 | 254.96M |
| September 25, 2024 | 250.49M |
| September 24, 2024 | 257.81M |
| September 23, 2024 | 254.56M |
| September 20, 2024 | 256.18M |
| September 19, 2024 | 262.68M |
| September 18, 2024 | 261.43M |
| September 17, 2024 | 263.07M |
| September 16, 2024 | 257.74M |
| September 13, 2024 | 263.07M |
| September 12, 2024 | 257.74M |
| September 11, 2024 | 254.05M |
| September 10, 2024 | 252.82M |
| September 09, 2024 | 247.08M |
| September 06, 2024 | 243.80M |
| September 05, 2024 | 251.59M |
| September 04, 2024 | 250.36M |
| September 03, 2024 | 249.95M |
| August 31, 2024 | 255.69M |
| August 30, 2024 | 229.14M |
| August 29, 2024 | 229.14M |
| August 28, 2024 | 225.51M |
| August 27, 2024 | 227.52M |
| August 26, 2024 | 232.76M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
134.59M
Minimum
Mar 25 2024
1.187B
Maximum
Nov 05 2021
548.00M
Average
492.22M
Median
Enterprise Value Benchmarks
| Accuray Inc | 279.05M |
| Masimo Corp | 8.324B |
| Perspective Therapeutics Inc | 524.04M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.80M |
| Revenue (Quarterly) | 67.49M |
| Total Expenses (Quarterly) | 76.20M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | 54.41% |
| Profit Margin (Quarterly) | -18.96% |
| Earnings Yield | -88.03% |
| Normalized Earnings Yield | -17.76 |